First Time Loading...

WELL Health Technologies Corp
TSX:WELL

Watchlist Manager
WELL Health Technologies Corp Logo
WELL Health Technologies Corp
TSX:WELL
Watchlist
Price: 3.59 CAD 0.28% Market Closed
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one WELL stock under the Base Case scenario is 9.02 CAD. Compared to the current market price of 3.59 CAD, WELL Health Technologies Corp is Undervalued by 60%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WELL Relative Value
Base Case
9.02 CAD
Undervaluation 60%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.1
P/S
P/S
Price to Sales
1.1
vs History
98
vs Industry
66
Median 3Y
1.8
Median 5Y
5.5
Industry
2.4
Forward
0.9
More Details
10 569.8
P/E
P/E
Price to Earnings
10 569.8
vs History
6
vs Industry
0
Median 3Y
-24.6
Median 5Y
-27.9
Industry
23.2
Forward
-117.3
More Details
13.2
P/OCF
P/OCF
Price to OCF
13.2
vs History
39
vs Industry
30
Median 3Y
14.3
Median 5Y
11.5
Industry
15.5
More Details
11.4
P/FCFE
P/FCFE
Price to FCFE
11.4
vs History
65
vs Industry
32
Median 3Y
12.3
Median 5Y
14.9
Industry
23.5
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
90
vs Industry
61
Median 3Y
1.5
Median 5Y
2.5
Industry
2.2
More Details
1.5
EV/S
EV/S
Enterprise Value to Sales
1.5
vs History
98
vs Industry
57
Median 3Y
2.2
Median 5Y
5.9
Industry
2.5
Forward
1.2
More Details
3.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.2
vs History
96
vs Industry
58
Median 3Y
4.2
Median 5Y
16.6
Industry
5.2
More Details
12.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.5
vs History
47
vs Industry
28
Median 3Y
15
Median 5Y
11.7
Industry
12.5
Forward
9.2
More Details
34.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
34.4
vs History
39
vs Industry
12
Median 3Y
41.3
Median 5Y
-32.6
Industry
17.2
Forward
24.7
More Details
18.1
EV/OCF
EV/OCF
Enterprise Value to OCF
18.1
vs History
36
vs Industry
25
Median 3Y
18.5
Median 5Y
15.4
Industry
15.1
More Details
20.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.6
vs History
34
vs Industry
24
Median 3Y
21
Median 5Y
17.1
Industry
19.7
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
87
vs Industry
62
Median 3Y
1.1
Median 5Y
1.6
Industry
2
More Details

Multiples Across Competitors

WELL Competitors Multiples
WELL Health Technologies Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
WELL Health Technologies Corp
TSX:WELL
866.7m CAD 1.1 10 569.8 12.5 34.4
US
Cigna Group
XMUN:CGN
96.6B EUR 0.5 20 10.3 13.7
US
Cigna Corp
NYSE:CI
103.7B USD 0.5 20.1 10.3 13.8
US
CVS Health Corp
NYSE:CVS
86.5B USD 0.2 10.4 8.9 8.9
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR 1.1 44.4 10.4 24.6
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD 1.4 38.6 11.8 17.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.3B EUR 0.7 -25.8 9.9 22.2
US
Quest Diagnostics Inc
NYSE:DGX
14.9B USD 1.6 17.7 10.6 14.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR 0.6 22 6.7 15.9
US
DaVita Inc
NYSE:DVA
11.9B USD 1 17.1 8.4 12.3
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
WELL intrinsic value, competitors valuation, and company profile.
DCF Valuation
WELL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WELL stock valuation using valuation multiples.
Wall Street Estimates
WELL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WELL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.